{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:11:38Z","timestamp":1791515498010,"version":"4.3.4"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel Ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Botulinum neurotoxins (BoNTs) are known as the most potent bacterial toxins, which can cause potentially deadly disease botulism. BoNT Serotype A (BoNT\/A) is the most studied serotype as it is responsible for most human botulism cases, and its formulations are extensively utilized in clinics for therapeutic and cosmetic applications. BoNT\/A has the longest-lasting effect in neurons compared to other serotypes, and there has been high interest in understanding how BoNT\/A manages to escape protein degradation machinery in neurons for months. Recent work demonstrated that an E3 ligase, HECTD2, leads to efficient ubiquitination of the BoNT\/A Light Chain (A\/LC); however, the dominant activity of a deubiquitinase (DUB), VCIP135, inhibits the degradation of the enzymatic component. Another DUB, USP9X, was also identified as a potential indirect contributor to A\/LC degradation. In this study, we screened a focused ubiquitin-proteasome pathway inhibitor library, including VCIP135 and USP9X inhibitors, and identified ten potential lead compounds affecting BoNT\/A mediated SNAP-25 cleavage in neurons in pre-intoxication conditions. We then tested the dose-dependent effects of the compounds and their potential toxic effects in cells. A subset of the lead compounds demonstrated efficacy on the stability and ubiquitination of A\/LC in cells. Three of the compounds, WP1130 (degrasyn), PR-619, and Celastrol, further demonstrated efficacy against BoNT\/A holotoxin in an <jats:italic>in vitro<\/jats:italic> post-intoxication model. Excitingly, PR-619 and WP1130 are known inhibitors of VCIP135 and USP9X, respectively. Modulation of BoNT turnover in cells by small molecules can potentially lead to the development of effective countermeasures against botulism.<\/jats:p>","DOI":"10.3389\/fphar.2021.763950","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T17:01:40Z","timestamp":1632762100000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Screening of a Focused Ubiquitin-Proteasome Pathway Inhibitor Library Identifies Small Molecules as Novel Modulators of Botulinum Neurotoxin Type A Toxicity"],"prefix":"10.3389","volume":"12","author":[{"given":"Edanur","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna P.","family":"Kota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha G.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1158\/0008-5472.CAN-06-0702","article-title":"Identification of New Compounds that Trigger Apoptosome-independent Caspase Activation and Apoptosis","volume":"66","author":"Aleo","year":"2006","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","article-title":"Activity-based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes","volume":"18","author":"Altun","year":"2011","journal-title":"Chem. Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum Toxin as a Biological Weapon: Medical and Public Health Management","volume":"285","author":"Arnon","year":"2001","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17513","DOI":"10.1038\/srep17513","article-title":"A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins","volume":"5","author":"Azarnia Tehran","year":"2015","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"111551","DOI":"10.1016\/j.biopha.2021.111551","article-title":"Potential Medicinal Value of Celastrol and its Synthesized Analogues for central Nervous System Diseases","volume":"139","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41418-020-00697-5","article-title":"Deubiquitylases in Developmental Ubiquitin Signaling and Congenital Diseases","volume":"28","author":"Basar","year":"2021","journal-title":"Cell Death Differ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fncel.2015.00159","article-title":"Accelerated Intoxication of GABAergic Synapses by Botulinum Neurotoxin A Disinhibits Stem Cell-Derived Neuron Networks Prior to Network Silencing","volume":"9","author":"Beske","year":"2015","journal-title":"Front Cel Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acs.jmedchem.6b01393","article-title":"Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and Ex Vivo Assays","volume":"60","author":"Bremer","year":"2017","journal-title":"J. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1021\/jacs.7b01084","article-title":"Metal Ions Effectively Ablate the Action of Botulinum Neurotoxin A","volume":"139","author":"Bremer","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fphar.2018.00104","article-title":"A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium Wilfordii Hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13010058","article-title":"Botulinum Toxin: An Update on Pharmacology and Newer Products in Development","volume":"13","author":"Choudhury","year":"2021","journal-title":"Toxins (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the Chains: Deubiquitylating Enzyme Specificity Begets Function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cel Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.20200421102102021c","article-title":"The Deubiquitylase USP9X Controls Ribosomal Stalling","volume":"220","author":"Clancy","year":"2021","journal-title":"J. Cel Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/2211068214560608","article-title":"High-throughput Viability Assay Using an Autonomously Bioluminescent Cell Line with a Bacterial Lux Reporter","volume":"20","author":"Class","year":"2015","journal-title":"J. Lab. Autom"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of Proteasome Deubiquitinating Activity as a New Cancer Therapy","volume":"17","author":"D'Arcy","year":"2011","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/164_2019_342","article-title":"The Structure and Classification of Botulinum Toxins","volume":"263","author":"Dong","year":"2021","journal-title":"Handb Exp. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.18632\/oncotarget.27219","article-title":"The Proteasome Deubiquitinase Inhibitor bAP15 Downregulates TGF-\u03b2\/Smad Signaling and Induces Apoptosis via UCHL5 Inhibition in Ovarian Cancer","volume":"10","author":"Fukui","year":"2019","journal-title":"Oncotarget"},{"key":"B18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-5193(79)90141-3","article-title":"Toxicity of Botulinum Toxin: a Stoichiometric Model for the Locus of its Extraordinary Potency and Persistence at the Neuromuscular junction","volume":"77","author":"Hanig","year":"1979","journal-title":"J. Theor. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating Enzymes and Drug Discovery: Emerging Opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B20","first-page":"487","article-title":"Clostridium Botulinum","author":"Johnson","year":"2019"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-10-1530","article-title":"Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis","volume":"70","author":"Kapuria","year":"2010","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bcp.2011.05.012","article-title":"Protein Cross-Linking as a Novel Mechanism of Action of a Ubiquitin-Activating Enzyme Inhibitor with Anti-tumor Activity","volume":"82","author":"Kapuria","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/bi0356698","article-title":"Uptake of Botulinum Neurotoxin into Cultured Neurons","volume":"43","author":"Keller","year":"2004","journal-title":"Biochemistry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.1074\/jbc.M010992200","article-title":"The Role of the Synaptic Protein Snap-25 in the Potency of Botulinum Neurotoxin Type A","volume":"276","author":"Keller","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.2174\/1568026614666141022093350","article-title":"Recent Advances in Botulinum Neurotoxin Inhibitor Development","volume":"14","author":"Kiris","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12640-015-9526-z","article-title":"SRC Family Kinase Inhibitors Antagonize the Toxicity of Multiple Serotypes of Botulinum Neurotoxin in Human Embryonic Stem Cell-Derived Motor Neurons","volume":"27","author":"Kiris","year":"2015","journal-title":"Neurotox Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1586\/14737159.2014.867808","article-title":"Recent Developments in Cell-Based Assays and Stem Cell Technologies for Botulinum Neurotoxin Research and Drug Discovery","volume":"14","author":"Kiris","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.scr.2011.01.002","article-title":"Embryonic Stem Cell-Derived Motoneurons Provide a Highly Sensitive Cell Culture Model for Botulinum Neurotoxin Studies, with Implications for High-Throughput Drug Discovery","volume":"6","author":"Kiris","year":"2011","journal-title":"Stem Cel Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0129264","DOI":"10.1371\/journal.pone.0129264","article-title":"Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays","volume":"10","author":"Kiris","year":"2015","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/acs.jmedchem.7b01710","article-title":"New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model","volume":"61","author":"Konstantinovic","year":"2018","journal-title":"J. Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e51915","DOI":"10.3791\/51915","article-title":"A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors","author":"Kota","year":"2014","journal-title":"J. Vis. Exp."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e20352","DOI":"10.1371\/journal.pone.0020352","article-title":"Accelerated Neuronal Cell Recovery from Botulinum Neurotoxin Intoxication by Targeted Ubiquitination","volume":"6","author":"Kuo","year":"2011","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101268","article-title":"The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-apoptotic Bcl-2 Protein: In Vitro and In Vivo Study","volume":"8","author":"Kuo","year":"2019","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.18632\/oncotarget.2431","article-title":"Screening for E3-Ubiquitin Ligase Inhibitors: Challenges and Opportunities","volume":"5","author":"Landr\u00e9","year":"2014","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/toxins2050978","article-title":"The Zinc-dependent Protease Activity of the Botulinum Neurotoxins","volume":"2","author":"Lebeda","year":"2010","journal-title":"Toxins (Basel)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/1087057111399191","article-title":"A Cell-Based High-Throughput Assay for the Screening of Small-Molecule Inhibitors of P53-MDM2 Interaction","volume":"16","author":"Li","year":"2011","journal-title":"J. Biomol. Screen."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.2147\/OTT.S187315","article-title":"Celastrol Induces Ubiquitin-dependent Degradation of mTOR in Breast Cancer Cells","volume":"11","author":"Li","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/acs.accounts.9b00261","article-title":"Strategies to Counteract Botulinum Neurotoxin A: Nature's Deadliest Biomolecule","volume":"52","author":"Lin","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1021\/jm060023+","article-title":"Discovery of a Nanomolar Inhibitor of the Human Murine Double Minute 2 (MDM2)-P53 Interaction through an Integrated, Virtual Database Screening Strategy","volume":"49","author":"Lu","year":"2006","journal-title":"J. Med. Chem."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.04.021","article-title":"Small Molecules as Tools for Functional Assessment of Deubiquitinating Enzyme Function","author":"Magin","year":"2021","journal-title":"Cell Chem Biol"},{"key":"B41","article-title":"Botulism as a Disease of Humans. Molecular Aspects of Botulinum Neurotoxin","volume-title":"Current Topics in Neurotoxicity","author":"Maslanka","year":"2014"},{"key":"B42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ebiom.2019.10.062","article-title":"Celastrol-induced Degradation of FANCD2 Sensitizes Pediatric High-Grade Gliomas to the DNA-Crosslinking Agent Carboplatin","volume":"50","author":"Metselaar","year":"2019","journal-title":"EBioMedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/s1044-7431(02)00016-7","article-title":"Dynamics of Motor Nerve Terminal Remodeling Unveiled Using SNARE-Cleaving Botulinum Toxins: the Extent and Duration Are Dictated by the Sites of SNAP-25 Truncation","volume":"22","author":"Meunier","year":"2003","journal-title":"Mol. Cel Neurosci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum Neurotoxin: a Marvel of Protein Design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"33116","DOI":"10.1038\/srep33116","article-title":"Ubiquitin Carboxyl-Terminal Hydrolase-L5 Promotes TGF\u03b2-1 Signaling by De-ubiquitinating and Stabilizing Smad2\/Smad3 in Pulmonary Fibrosis","volume":"6","author":"Nan","year":"2016","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1110\/ps.083450408","article-title":"Characterization of Ubiquitin and Ubiquitin-Like-Protein Isopeptidase Activities","volume":"17","author":"Nicholson","year":"2008","journal-title":"Protein Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","article-title":"Principles of Ubiquitin-dependent Signaling","volume":"34","author":"Oh","year":"2018","journal-title":"Annu. Rev. Cel Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"129933","DOI":"10.1016\/j.bbagen.2021.129933","article-title":"Botulinum Neurotoxin Inhibitor Binding Dynamics and Kinetics Relevant for Drug Design","volume":"1865","author":"Patel","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11090528","article-title":"Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches","volume":"11","author":"Rasetti-Escargueil","year":"2019","journal-title":"Toxins (Basel)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/jcmm.12702","article-title":"p97\/VCP Promotes Cullin\u2010 RING \u2010ubiquitin\u2010ligase\/proteasome\u2010dependent Degradation of I\u03baB\u03b1 and the Preceding Liberation of RelA from Ubiquitinated I\u03baB\u03b1","volume":"20","author":"Schweitzer","year":"2016","journal-title":"J. Cel. Mol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.1039\/c5cc00677e","article-title":"Toward the Discovery of Dual Inhibitors for Botulinum Neurotoxin A: Concomitant Targeting of Endocytosis and Light Chain Protease Activity","volume":"51","author":"Seki","year":"2015","journal-title":"Chem. Commun. (Camb)"},{"key":"B52","first-page":"839","article-title":"Cure of Experimental Botulism and Antibotulismic Effect of Toosendanin","volume":"25","author":"Shi","year":"2004","journal-title":"Acta Pharmacol. Sin"},{"key":"B53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-3-642-33570-9_9","article-title":"Persistence of Botulinum Neurotoxin Inactivation of Nerve Function","volume":"364","author":"Shoemaker","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fbioe.2018.00080","article-title":"Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance","volume":"6","author":"Thirunavukkarasu","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/adt.2010.0317","article-title":"Characterization of Selective Ubiquitin and Ubiquitin-like Protease Inhibitors Using a Fluorescence-Based Multiplex Assay Format","volume":"9","author":"Tian","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2013-05-500033","article-title":"A Novel Small Molecule Inhibitor of Deubiquitylating Enzyme USP14 and UCHL5 Induces Apoptosis in Multiple Myeloma and Overcomes Bortezomib Resistance","volume":"123","author":"Tian","year":"2014","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"16554","DOI":"10.1073\/pnas.1008302107","article-title":"Targeting Botulinum Neurotoxin Persistence by the Ubiquitin-Proteasome System","volume":"107","author":"Tsai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1621076114","article-title":"Deubiquitinating Enzyme VCIP135 Dictates the Duration of Botulinum Neurotoxin Type A Intoxication","volume-title":"Proc. Natl. Acad. Sci. U S A","author":"Tsai","year":"2017"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.05.012","article-title":"Identification and Validation of Selective Deubiquitinase Inhibitors","author":"Varca","year":"2021","journal-title":"Cel Chem Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132891","article-title":"Symptomatic Treatment of Botulism with a Clinically Approved Small Molecule","volume":"5","author":"Vazquez-Cintron","year":"2020","journal-title":"JCI Insight"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftw059","article-title":"Control of Autoimmune Inflammation by Celastrol, a Natural Triterpenoid","volume":"74","author":"Venkatesha","year":"2016","journal-title":"Pathog. Dis."},{"key":"B62","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/jm500033r","article-title":"Second Generation Steroidal 4-aminoquinolines Are Potent, Dual-Target Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease and P. Falciparum Malaria","volume":"57","author":"Videnovic","year":"2014","journal-title":"J. Med. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/cas.12679","article-title":"Celastrol Induces Proteasomal Degradation of FANCD2 to Sensitize Lung Cancer Cells to DNA Crosslinking Agents","volume":"106","author":"Wang","year":"2015","journal-title":"Cancer Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1073\/pnas.1322198111","article-title":"Ablation of the Oncogenic Transcription Factor ERG by Deubiquitinase Inhibition in Prostate Cancer","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B65","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1042\/BST20190535","article-title":"Small Molecules that Target the Ubiquitin System","volume":"48","author":"Wu","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"B66","doi-asserted-by":"publisher","first-page":"79515","DOI":"10.18632\/oncotarget.12819","article-title":"Deubiquitinase USP9X Deubiquitinates \u03b2-catenin and Promotes High Grade Glioma Cell Growth","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","first-page":"9472","DOI":"10.1158\/0008-5472.CAN-07-0568","article-title":"Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.763950\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T17:01:54Z","timestamp":1632762114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.763950\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":67,"alternative-id":["10.3389\/fphar.2021.763950"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.763950","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"article-number":"763950"}}